The Cigna Group stock: Q3 report due November 19 after $73.7B revenue
Published on 11/15/2026 at 17:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Cigna investors should watch
- The Cigna Group is scheduled to publish third-quarter results on November 19, covering the period ended September 30, 2026.
- Third-quarter adjusted income from operations reached $2.1 billion, while management raised its full-year adjusted earnings outlook.
- Pharmacy Benefit Services remained a key operating issue after its quarterly adjusted income from operations declined from the prior year.
The Cigna Group is scheduled to release its third-quarter 2026 results on Thursday, November 19. The company's official newsroom lists the release for that date, while its latest report provides the operating context: third-quarter revenue reached $73.7 billion for the period ended September 30, 2026.
The Cigna Group newsroom identifies November 19 as the next quarterly reporting date. The release will give investors a fresh view of medical cost trends, pharmacy-benefit performance and the company's full-year outlook.
Operating signals before the release
In the third quarter, adjusted income from operations was $2.1 billion, or $7.98 per share, compared with $2.1 billion, or $7.83 per share, a year earlier. Shareholders' net income was $1.4 billion, or $5.47 per share, versus $1.9 billion, or $6.98 per share, in the prior-year quarter. The company attributed the difference primarily to the absence of an after-tax gain on a sale recognized a year earlier.
The official third-quarter release said the company raised its full-year 2026 adjusted income from operations outlook to at least $30.60 per share. Cigna Healthcare's adjusted income from operations, pre-tax, rose 15% year over year to $1.193 billion, while Evernorth Health Services reported $1.829 billion, down from $1.903 billion. Within Evernorth, Pharmacy Benefit Services produced $765 million, down 22% year over year, making that business a central item for the November 19 update.
What the November report may clarify
The upcoming release should provide the next formal update on whether the higher full-year earnings floor remains intact and how the company is managing pressure in pharmacy-benefit operations. Investors will also have a new quarterly view of Cigna Healthcare's medical care ratio, which stood at 85.0% in the third quarter, and of revenue trends across the two main operating segments.
The Cigna Group stock traded at 267.15 euros on Lang & Schwarz at 17:30 CET on Sunday, November 15.
The Cigna Group at a glance
- Company: The Cigna Group
- ISIN: US1255231003
- Ticker: CI
- Primary exchange: NYSE
- Lang & Schwarz quote: 267.15 euros, Sunday, November 15, 2026, 17:30 CET
- Third-quarter revenue: $73.7 billion for the period ended September 30, 2026
- Full-year adjusted earnings outlook: at least $30.60 per share for 2026
The broader U.S. market backdrop is covered in Current market reports.
